Chemotherapy-Related Toxic Effects and Quality of Life and Physical Functioning in Older Patients

被引:17
|
作者
Baltussen, Joosje C. [1 ,2 ]
de Glas, Nienke A. [2 ]
van Holstein, Yara [3 ]
van der Elst, Marjan [3 ]
Trompet, Stella [3 ]
Uit den Boogaard, Anna [3 ]
van der Plas-Krijgsman, Willeke [2 ]
Labots, Geert [4 ]
Holterhues, Cynthia [4 ]
van der Bol, Jessica M. [5 ]
Mammatas, Lemonitsa H. [6 ]
Liefers, Gerrit-Jan [7 ]
Slingerland, Marije [2 ]
van den Bos, Frederiek [3 ]
Mooijaart, Simon P. [3 ]
Portielje, Johanneke E. A. [2 ]
机构
[1] Leiden Univ, Med Ctr, Dept Med Oncol, Albinusdreef 2,Postzone C7-Q, NL-9600 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Med Oncol, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands
[4] Haga Hosp, Dept Internal Med, The Hague, Netherlands
[5] Reinier de Graaf Hosp, Dept Geriatr, Delft, Netherlands
[6] Reinier de Graaf Hosp, Dept Med Oncol, Delft, Netherlands
[7] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
关键词
COMPREHENSIVE GERIATRIC ASSESSMENT; INSTRUMENTAL ACTIVITIES; ELDERLY-PATIENTS; CANCER; FRAILTY; INDEX; TOLERANCE; CONSENSUS; JUDGMENT; DECLINE;
D O I
10.1001/jamanetworkopen.2023.39116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Although older patients are at increased risk of developing grade 3 or higher chemotherapy-related toxic effects, no studies, to our knowledge, have focused on the association between toxic effects and quality of life (QOL) and physical functioning.Objective To investigate the association between grade 3 or higher chemotherapy-related toxic effects and QOL and physical functioning over time in older patients.Design, Setting, and Participants In this prospective, multicenter cohort study, patients aged 70 years or older who were scheduled to receive chemotherapy with curative or palliative intent and a geriatric assessment were included. Patients were treated with chemotherapy between December 2015 and December 2021. Quality of life and physical functioning were analyzed at baseline and after 6 months and 12 months.Exposures Common Terminology Criteria for Adverse Events grade 3 or higher chemotherapy-related toxic effects.Main Outcomes and Measures The main outcome was a composite end point, defined as a decline in QOL and/or physical functioning or mortality at 6 months and 12 months after chemotherapy initiation. Associations between toxic effects and the composite end point were analyzed with multivariable logistic regression models.Results Of the 276 patients, the median age was 74 years (IQR, 72-77 years), 177 (64%) were male, 196 (71%) received chemotherapy with curative intent, and 157 (57%) had gastrointestinal cancers. Among the total patients, 145 (53%) had deficits in 2 or more of the 4 domains of the geriatric assessment and were classified as frail. Grade 3 or higher toxic effects were observed in 94 patients (65%) with frailty and 66 (50%) of those without frailty (P = .01). Decline in QOL and/or physical functioning or death was observed in 76% of patients with frailty and in 64% to 68% of those without frailty. Among patients with frailty, grade 3 or higher toxic effects were associated with the composite end point at 6 months (odds ratio [OR], 2.62; 95% CI, 1.14-6.05) but not at 12 months (OR, 1.09; 95% CI, 0.45-2.64) and were associated with mortality at 12 months (OR, 3.54; 95% CI, 1.50-8.33). Toxic effects were not associated with the composite end point in patients without frailty (6 months: OR, 0.76; 95% CI, 0.36-1.64; 12 months: OR, 1.06; 95% CI, 0.46-2.43).Conclusions and Relevance In this prospective cohort study of 276 patients aged 70 or older who were treated with chemotherapy, patients with frailty had more grade 3 or higher toxic effects than those without frailty, and the occurrence of toxic effects was associated with a decline in QOL and/or physical functioning or mortality after 1 year. Toxic effects were not associated with poor outcomes in patients without frailty. Pretreatment frailty screening and individualized treatment adaptions could prevent a treatment-related decline of remaining health.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Chemotherapy-Related Polyneuropathy Effect on Quality of Life in Patients with Lymphoma
    Kim, Byung-Jo
    Cho, S. Charles
    Roh, Hak-Jae
    So, Yuen T.
    NEUROLOGY, 2009, 72 (11) : A219 - A219
  • [2] Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer
    Bruno Vincenzi
    Gaia Schiavon
    Francesco Pantano
    Daniele Santini
    Giuseppe Tonini
    Nature Clinical Practice Oncology, 2008, 5 : 455 - 465
  • [3] Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer
    Vincenzi, Bruno
    Schiavon, Gaia
    Pantano, Francesco
    Santini, Daniele
    Tonini, Giuseppe
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (08): : 455 - 465
  • [4] Chemotherapy-related cognitive impairment in older patients with cancer
    Loh, Kah Poh
    Janelsins, Michelle C.
    Mohile, Supriya G.
    Holmes, Holly M.
    Hsu, Tina
    Inouye, Sharon K.
    Karuturi, Meghan S.
    Kimmick, Gretchen G.
    Lichtman, Stuart M.
    Magnuson, Allison
    Whitehead, Mary I.
    Wong, Melisa L.
    Ahles, Tim A.
    JOURNAL OF GERIATRIC ONCOLOGY, 2016, 7 (04) : 270 - 280
  • [5] Interpretation of the Efficacy of Multidisciplinary Geriatric Assessment Intervention on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
    Matsuoka, Ayumu
    Fujimori, Maiko
    JAMA ONCOLOGY, 2022, 8 (04) : 646 - 647
  • [6] The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life
    Carole Farrell
    Sarah G. Brearley
    Mark Pilling
    Alex Molassiotis
    Supportive Care in Cancer, 2013, 21 : 59 - 66
  • [7] The Impact of Outpatient Chemotherapy-Related Adverse Events on the Quality of Life of Breast Cancer Patients
    Tachi, Tomoya
    Teramachi, Hitomi
    Tanaka, Kazuhide
    Asano, Shoko
    Osawa, Tomohiro
    Kawashima, Azusa
    Yasuda, Masahiro
    Mizui, Takashi
    Nakada, Takumi
    Noguchi, Yoshihiro
    Tsuchiya, Teruo
    Goto, Chitoshi
    PLOS ONE, 2015, 10 (04):
  • [8] The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life
    Farrell, Carole
    Brearley, Sarah G.
    Pilling, Mark
    Molassiotis, Alex
    SUPPORTIVE CARE IN CANCER, 2013, 21 (01) : 59 - 66
  • [9] Quality of Life and Chemotherapy-related Symptoms of Turkish Cancer Children Undergoing Chemotherapy
    Arslan, Fatma Tas
    Basbakkal, Zumrut
    Kantar, Mehmet
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (03) : 1761 - 1768
  • [10] Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma
    Kim, Byung-Jo
    Park, Ha-Rim
    Roh, Hak Jae
    Jeong, Du-Shin
    Kim, Byung Soo
    Park, Kun-Woo
    Cho, S. Charles
    So, Yuen T.
    Oh, Sung Yong
    Kim, Seok Jin
    QUALITY OF LIFE RESEARCH, 2010, 19 (08) : 1097 - 1103